hydroflumethiazide and methyldopa

hydroflumethiazide has been researched along with methyldopa in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (33.33)	18.7374
1990's	1 (11.11)	18.2507
2000's	2 (22.22)	29.6817
2010's	3 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Berry, C; Finnerty, FA; Gyftopoulos, A; McKenney, A	1
Akinkugbe, OO; Carlisle, R; Olatunde, A	1
Kadiri, S; Salako, BL	1
KINOSHITA, Y; YAMADA, A	1

Reviews

2 review(s) available for hydroflumethiazide and methyldopa

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
[ANTIHYPERTENSIVE DRUGS]. Rinsho naika shonika. Internal medicine and pediatrics, 1963, Volume: 18 Topics: Antihypertensive Agents; Bretylium Compounds; Chlorothiazide; Ganglionic Blockers; Guanethidine; Hydralazine; Hydrochlorothiazide; Hydroflumethiazide; Methyldopa; Rauwolfia; Sympatholytics; Trichlormethiazide; Veratrum; Veratrum Alkaloids	1963

Trials

1 trial(s) available for hydroflumethiazide and methyldopa

Article	Year
Step 2 regimens in hypertension. An assessment. JAMA, 1979, Feb-09, Volume: 241, Issue:6 Topics: Adult; Aged; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hydroflumethiazide; Hypertension; Male; Methyldopa; Middle Aged; Propranolol; Reserpine	1979

Other Studies

6 other study(ies) available for hydroflumethiazide and methyldopa

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
Beta-adrenergic blockers in the treatment of hypertension--experience with propranolol at Ibadan, Nigeria. East African medical journal, 1977, Volume: 54, Issue:4 Topics: Adult; Aged; Debrisoquin; Drug Therapy, Combination; Female; Humans; Hydroflumethiazide; Hypertension; Male; Methyldopa; Middle Aged; Nigeria; Propranolol	1977
Parodoxical rise in urinary albumin levels after treatment of essential hypertension. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1997, Volume: 87, Issue:9 Topics: Adult; Aged; Albuminuria; Antihypertensive Agents; Creatinine; Female; Humans; Hydroflumethiazide; Hypertension; Male; Methyldopa; Middle Aged; Prazosin	1997